Pfizer Inc. (NYSE: PFE) stock closed at 51.59 per share at the end of the most recent trading day (a 3.01% change compared to the prior day closing price) with a volume of 15.70M shares and market capitalization of 289.52B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 78500 people. Pfizer Inc. CEO is Albert Bourla.

The one-year performance of Pfizer Inc. stock is 27.81%, while year-to-date (YTD) performance is -12.62%. PFE stock has a five-year performance of 51.01%. Its 52-week range is between 38.82 and 61.71, which gives PFE stock a 52-week price range ratio of 55.83%

Pfizer Inc. currently has a PE ratio of 10.70, a price-to-book (PB) ratio of 3.17, a price-to-sale (PS) ratio of 2.83, a price to cashflow ratio of 7.70, a PEG ratio of 2.32, a ROA of 14.96%, a ROC of 23.27% and a ROE of 33.92%. The company’s profit margin is 27.11%, its EBITDA margin is 36.90%, and its revenue ttm is $92.37 Billion , which makes it $16.46 revenue per share.

Of the last four earnings reports from Pfizer Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.95 for the next earnings report. Pfizer Inc.’s next earnings report date is 28th Jul 2022.

The consensus rating of Wall Street analysts for Pfizer Inc. is Moderate Buy (1.67), with a target price of $60.5, which is +17.25% compared to the current price. The earnings rating for Pfizer Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Pfizer Inc. has a dividend yield of 3.44% with a dividend per share of $1.60 and a payout ratio of 92.00%.

Pfizer Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 7.21, ATR14 : 1.51, CCI20 : 7.00, Chaikin Money Flow : 0.01, MACD : -0.60, Money Flow Index : 48.94, ROC : -4.39, RSI : 55.00, STOCH (14,3) : 64.13, STOCH RSI : 1.00, UO : 57.88, Williams %R : -35.87), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Pfizer Inc. in the last 12-months were: Alexander R. Mackenzie (Sold 41 360 shares of value $2 244 193 ), Angela Hwang (Option Excercise at a value of $325 530), Angela Hwang (Sold 26 170 shares of value $1 298 002 ), Douglas M. Lankler (Option Excercise at a value of $1 989 350), Douglas M. Lankler (Sold 78 273 shares of value $4 065 854 ), Frank A. D'Amelio (Option Excercise at a value of $3 255 296), Jennifer B. Damico (Option Excercise at a value of $569 843), Jennifer B. Damico (Sold 12 379 shares of value $616 980 ), John Douglas Young (Sold 150 000 shares of value $7 508 731 ), Michael McDermott (Option Excercise at a value of $315 904), Mikael Dolsten (Option Excercise at a value of $8 275 962), Mikael Dolsten (Sold 123 566 shares of value $6 152 193 ), Payal Sahni (Sold 1 408 shares of value $70 175 ), Rady A. Johnson (Option Excercise at a value of $750 515), Rady A. Johnson (Sold 19 000 shares of value $1 015 042 ), Sally Susman (Option Excercise at a value of $1 627 648), Sally Susman (Sold 43 608 shares of value $2 377 434 ), William R. Carapezzi (Option Excercise at a value of $542 541), William R. Carapezzi (Sold 32 908 shares of value $1 645 400 )